AstraZeneca AB et al v. Alembic Pharmaceuticals Limited
AstraZeneca Pharmaceuticals LP and AstraZeneca AB |
Alembic Global Holding SA, Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc. |
1:2021cv00982 |
July 2, 2021 |
US District Court for the District of Delaware |
Richard G Andrews |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on July 23, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 13 SO ORDERED Granting (D.I. 149 20-cv-202-RGA; D.I. 12 in 21-cv-982-RGA) Stipulation and Proposed Order Regarding Case Consolidation. Signed by Judge Richard G. Andrews on 7/23/2021. Associated Cases: 1:20-cv-00202-RGA, 1:21-cv-00982-RGA(nms) |
Filing 12 STIPULATION and [Proposed] Order Regarding Case Consolidation by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
Filing 11 SO ORDERED Granting #10 Stipulation and Order Dismissing Without Prejudice Defendants Alembic Global Holdings SA and Alembic Pharmaceuticals, Inc., and Amending Caption to Reflect Same (*Party Alembic Global Holding SA and Alembic Pharmaceuticals, Inc. terminated). Signed by Judge Richard G. Andrews on 7/21/2021. (nms) |
Filing 10 STIPULATION to dismiss without prejudice Defendants Alembic Global Holding SA and Alembic Pharmaceuticals, Inc. and amending case caption by Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Dorsney, Kenneth) |
Filing 9 DECLARATION of Service on Alembic Gobal Holding SA made on July 2, 2021, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) Modified on 7/21/2021 (nms). |
Filing 8 DECLARATION of Service on Alembic Pharmaceuticals Limited made on July 2, 2021, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibits A-B)(Silver, Daniel) Modified on 7/21/2021 (nms). |
Filing 7 SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. Alembic Pharmaceuticals, Inc. served on 7/2/2021, answer due 7/23/2021. (Silver, Daniel) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (twk) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB, AstraZeneca Pharmaceuticals LP filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (twk) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,183,020. (twk) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/8/2021. Date of Expiration of Patent: 1/2/2035. Thirty Month Stay Deadline: 12/8/2023. (twk) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
Filing 1 COMPLAINT filed against Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3649134.) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.